Recombinant Fibronectin Fragment for Stem Cell Proliferation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing stem cells are inefficient in terms of proliferation rate and quality, particularly when using fibronectin or its fragments, which can introduce viral contaminants and are not suitable for rapid large-scale production for regenerative medicine.
Innovation Solution
Culturing stem cells with recombinant fibronectin fragments, specifically polypeptides comprising human fibronectin III repeats, which are functionally equivalent to full-length fibronectin but with modifications such as substitutions, deletions, or additions of amino acids, to enhance proliferation and maintain undifferentiated states.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If full-length fibronectin or commercially available 120 k-fr is used as substrate for culturing stem cells, then stem cells can be cultured, but the proliferation rate is slow and there is a high risk of viral contamination from natural fibronectin sources
Solution Approach 1:
The invention segments the full-length fibronectin molecule into specific type III repeat domains (III-1 to III-6, and/or III-8 to III-14) to create recombinant fibronectin fragments. These segmented fragments eliminate viral contamination risks from full-length natural fibronectin while maintaining essential cell-binding functions, thereby improving safety without sacrificing proliferation rate
Solution Approach 2:
The invention changes the molecular weight parameter of fibronectin from full-length (250 kDa) to specific fragments (60-120 kDa), and further optimizes by selecting particular type III repeat combinations. This parameter change removes viral contaminants while preserving the RGD and other cell-binding motifs necessary for stem cell proliferation
2Ease of manufacture
If natural fibronectin is used as substrate, then stem cells can be cultured, but there is a high risk that viruses and other contaminants from origin organisms are introduced
Solution Approach 1:
The invention extracts only the essential type III repeat domains from full-length fibronectin, removing the portions that may contain viral contaminants. By synthesizing only the critical functional domains (III-1 to III-6 and/or III-8 to III-14) through recombinant DNA technology, the solution eliminates viral risks while retaining stem cell culture functionality
Solution Approach 2:
The invention creates recombinant copies of specific fibronectin type III repeat domains using synthetic DNA sequences. These copied fragments replicate the essential cell-binding functions of natural fibronectin without containing any viral genetic material, thereby providing a safe alternative for stem cell culture
3Quantity of substance
If conventional fibronectin methods are used, then stem cell culture is possible, but a sufficient amount of stem cells cannot be produced in a short period of time
Solution Approach 1:
The invention optimizes the dynamic characteristics of fibronectin-stem cell interaction by selecting specific type III repeat combinations that maximize binding affinity and signaling efficiency. This dynamic optimization accelerates stem cell proliferation kinetics, enabling faster production of sufficient cell quantities
Solution Approach 2:
The invention creates composite functional domains by combining specific type III repeat sequences (III-1 to III-6 and/or III-8 to III-14) in defined arrangements. This composite structure integrates multiple cell-binding motifs and signaling domains into a single recombinant protein that enhances proliferation efficiency and reduces culture time
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Stem cells can be efficiently proliferated by culturing the stem cells in the presence of a novel recombinant fibronectin fragment.